DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,736,857 | -2.9% | 10,954 | -3.0% | 0.67% | -7.3% |
Q1 2024 | $2,818,839 | +9.1% | 11,288 | +1.1% | 0.73% | -12.6% |
Q4 2023 | $2,584,068 | -48.1% | 11,170 | -44.3% | 0.83% | -58.4% |
Q3 2023 | $4,974,405 | +21.3% | 20,050 | +17.3% | 2.00% | +21.2% |
Q2 2023 | $4,102,560 | -20.4% | 17,094 | -16.4% | 1.65% | -28.5% |
Q1 2023 | $5,152,202 | -7.1% | 20,442 | -2.1% | 2.31% | -11.6% |
Q4 2022 | $5,544,093 | +0.6% | 20,888 | -2.1% | 2.61% | -2.9% |
Q3 2022 | $5,510,000 | +5.3% | 21,334 | +3.3% | 2.69% | +21.6% |
Q2 2022 | $5,234,000 | -16.5% | 20,644 | -3.4% | 2.21% | +13.0% |
Q1 2022 | $6,271,000 | -9.2% | 21,378 | +1.8% | 1.96% | -1.6% |
Q4 2021 | $6,907,000 | +11.4% | 20,994 | +3.0% | 1.99% | -1.4% |
Q3 2021 | $6,202,000 | +13.4% | 20,373 | -0.0% | 2.02% | +14.7% |
Q2 2021 | $5,469,000 | +23.0% | 20,379 | +3.1% | 1.76% | +3.5% |
Q1 2021 | $4,448,000 | +6.5% | 19,761 | +5.1% | 1.70% | +5.7% |
Q4 2020 | $4,176,000 | +3.9% | 18,799 | -17.6% | 1.61% | -9.3% |
Q3 2020 | $4,020,000 | +22.0% | 22,812 | +22.4% | 1.77% | +6.3% |
Q2 2020 | $3,296,000 | +39.0% | 18,637 | +8.8% | 1.66% | -9.7% |
Q1 2020 | $2,372,000 | -16.2% | 17,135 | -7.0% | 1.84% | +13.1% |
Q4 2019 | $2,829,000 | – | 18,431 | – | 1.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |